Theseus Pharmaceuticals Inc at Wedbush PacGrow Healthcare Conference (Virtual) Transcript

Aug 10, 2022 / 02:20PM GMT
David Matthew Nierengarten - Wedbush Securities Inc., Research Division - MD & Head of Healthcare of Equity Research

Thank you, everyone, for joining us today at the Wedbush PacGrow Healthcare Conference. Today, we're going to be discussing targeted oncology and several different flavors here. With us today, we have representatives from 4 of those companies, and I will turn the mic over to them in one second to give a brief intro or at least say who they are.

(Operator Instructions) And we will just turn it over. Nima, let's start with you, and we'll go kind of round-robin on a quick intro.

Nima Farzan - Kinnate Biopharma Inc. - President, CEO & Director

All right. Thanks, David. Thanks for having me. Nima Farzan, I'm the CEO of Kinnate Biopharma.

David Matthew Nierengarten - Wedbush Securities Inc., Research Division - MD & Head of Healthcare of Equity Research

Tim?

Timothy P. Clackson - Theseus Pharmaceuticals, Inc. - CEO, President & Director

Hi,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot